As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a study titled: Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment.
Independent expert commentary is provided by Dr Scott Dunkley, a senior staff specialist haematologist at Royal Prince Alfred Hospital, Sydney and the Thrombosis and Pregnancy Clinic at Charles Perkins Centre, University of Sydney.
Please login below to download this issue (PDF)